JUSTIN LAPOLLO: Open Payments
NPI 1811124340 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 55 payments from 12 companies in 2025. Trend: 2023 $735 · 2024 $1,068 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $323 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $287 |
| Janssen Pharmaceuticals, Inc | 4 | $177 |
| ABBVIE INC. | 6 | $108 |
| Axsome Therapeutics, Inc. | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Lundbeck LLC | 3 | $60 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Alkermes, Inc. | 2 | $47 |
| Tris Pharma Inc | 1 | $29 |
Products named: CAPLYTA, HETLIOZ, SPRAVATO, FANAPT, VRAYLAR, Auvelity, TRINTELLIX, REXULTI.
Industry payments across TN — which companies pay providers there.
